Paul A. Marks
- Molecular Biology top 0.1%
- Histone Deacetylase Inhibitors Research 59
- Protein Degradation and Inhibitors 33
- Epigenetics and DNA Methylation 16
- Ubiquitin and proteasome pathways 14
- Hematology top 0.2%
- Genetics top 0.2%
- Hemoglobinopathies and Related Disorders 44
- Oncology top 0.5%
- Peptidase Inhibition and Analysis 19
- Physiology top 0.2%
- Erythrocyte Function and Pathophysiology 41
-
- Neonatal Health and Biochemistry 14
- Co-authors
- Richard A. RifkindVictoria M. RichonRonald BreslowMilos DokmanovicWilliam Kevin KellyThomas A. MillerTodd W. SandhoffXuejun Jiang
- Cited by
- Molecular BiologyHematologyGenetics
- Journals
- Proceedings of the National Academy of Sciences (33 papers)Journal of Clinical Investigation (15 papers)Annals of the New York Academy of Sciences (11 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Paul A. Marks
196 papers receiving 21.5k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Molecular Biology 17.9k
- Hematology 2.2k
- Genetics 1.8k
- Oncology 4.6k
- Physiology 600
Countries citing papers authored by Paul A. Marks
This map shows the geographic impact of Paul A. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Marks more than expected).
Fields of papers citing papers by Paul A. Marks
This network shows the impact of papers produced by Paul A. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Marks. The network helps show where Paul A. Marks may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul A. Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 1 | |
| 2 | 2012 | 19 | |
| 3 | 2008 | 12 | |
| 4 | 2008 | 1 | |
| 5 | 2006 | 57 | |
| 6 | 2005 | 345 | |
| 7 | 2005 | 263 | |
| 8 | 2005 | 264 | |
| 9 | 2004 | 71 | |
| 10 | Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's diseasebreakdown → | 2003 | 667 |
| 11 | 2002 | 206 | |
| 12 | The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. | 2001 | 302 |
| 13 | 1999 | 29 | |
| 14 | 1999 | 9 | |
| 15 | 1994 | 24 | |
| 16 | 1987 | 20 | |
| 17 | Genetics, cell differentiation, and cancer | 1985 | 20 |
| 18 | Tumor promoter-induced adhesion of the DS19 clone of murine erythroleukemia cells. | 1979 | 40 |
| 19 | Differentiation of normal and neoplastic hematopoietic cells | 1978 | 325 |
| 20 | Genetic control of hemoglobin synthesis and the thalassemia syndromes. | 1969 | 5 |
About Paul A. Marks
Paul A. Marks is a scholar working on Genetics, Hematology, Physiology, Molecular Biology and Clinical Biochemistry, having authored 202 papers that have together received 22.6k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (59 papers), Hemoglobinopathies and Related Disorders (44 papers), Erythrocyte Function and Pathophysiology (41 papers), Protein Degradation and Inhibitors (33 papers), Peptidase Inhibition and Analysis (19 papers), Epigenetics and DNA Methylation (16 papers), Neonatal Health and Biochemistry (14 papers) and Ubiquitin and proteasome pathways (14 papers). The work is most often cited by research in Molecular Biology (17.9k citations), Hematology (2.2k citations), Genetics (1.8k citations), Oncology (4.6k citations) and Physiology (600 citations). Paul A. Marks has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Richard A. Rifkind, Victoria M. Richon, Ronald Breslow, Milos Dokmanovic, William Kevin Kelly, Thomas A. Miller, Todd W. Sandhoff, Xuejun Jiang, Xianbo Zhou and Lang Ngo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation, Annals of the New York Academy of Sciences, Journal of Biological Chemistry and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.